ATE311101T1 - Abbildung von transgenen markern - Google Patents

Abbildung von transgenen markern

Info

Publication number
ATE311101T1
ATE311101T1 AT02752606T AT02752606T ATE311101T1 AT E311101 T1 ATE311101 T1 AT E311101T1 AT 02752606 T AT02752606 T AT 02752606T AT 02752606 T AT02752606 T AT 02752606T AT E311101 T1 ATE311101 T1 AT E311101T1
Authority
AT
Austria
Prior art keywords
imaging marker
radiolabeled
cells
illustration
animals
Prior art date
Application number
AT02752606T
Other languages
English (en)
Inventor
Jeffrey Paul Northrop
Joshua Morris Star-Lack
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE311101T1 publication Critical patent/ATE311101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Mushroom Cultivation (AREA)
  • User Interface Of Digital Computer (AREA)
AT02752606T 2001-07-30 2002-07-29 Abbildung von transgenen markern ATE311101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30891901P 2001-07-30 2001-07-30
PCT/US2002/023962 WO2003011020A1 (en) 2001-07-30 2002-07-29 Imaging marker transgenes

Publications (1)

Publication Number Publication Date
ATE311101T1 true ATE311101T1 (de) 2005-12-15

Family

ID=23195922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02752606T ATE311101T1 (de) 2001-07-30 2002-07-29 Abbildung von transgenen markern

Country Status (6)

Country Link
US (1) US20030033616A1 (de)
EP (1) EP1418808B1 (de)
AT (1) ATE311101T1 (de)
DE (1) DE60207733T2 (de)
ES (1) ES2253548T3 (de)
WO (1) WO2003011020A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7693399B2 (en) * 2002-07-11 2010-04-06 Lg Electronics Inc. Method for providing program specific information recorded on high density disc medium
AU2005287047A1 (en) * 2004-09-17 2006-03-30 University Of Utah Research Foundation Imaging reporters of transgene expression
EP2009990B1 (de) * 2006-04-07 2016-09-21 The Board of Regents of The University of Texas System Verfahren und zusammensetzungen in verbindung mit adenoassoziierten virus-phagenpartikeln
BRPI0712073B8 (pt) 2006-05-17 2021-05-25 Hoffmann La Roche ácido nucléico para produção de um polipeptídio ou proteína heteróloga
US9758779B2 (en) 2008-08-28 2017-09-12 Novartis Ag Cell surface display of polypeptide isoforms by stop codon readthrough
EP3472198B1 (de) 2016-09-29 2020-03-04 H. Hoffnabb-La Roche Ag Verbessertes verfahren zur auswahl von polypeptidproduzierenden zellen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
WO1990000625A1 (en) * 1988-07-14 1990-01-25 Monoclonetics International, Inc. Pre-screening for depletion and enrichment of specific b-cells
US5185142A (en) * 1989-07-28 1993-02-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy
US6017754A (en) * 1995-08-24 2000-01-25 Invitrogen Corporation System for isolating and identifying eukaryotic cells transfected with genes and vectors, host cells and methods thereof
WO2001057212A1 (en) * 2000-02-02 2001-08-09 Iconix Pharmaceuticals, Inc. Rapid, parallel identification of cell lines

Also Published As

Publication number Publication date
DE60207733T2 (de) 2006-06-29
EP1418808B1 (de) 2005-11-30
EP1418808A1 (de) 2004-05-19
EP1418808A4 (de) 2004-09-15
WO2003011020A1 (en) 2003-02-13
US20030033616A1 (en) 2003-02-13
ES2253548T3 (es) 2006-06-01
DE60207733D1 (de) 2006-01-05

Similar Documents

Publication Publication Date Title
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
PT1135467E (pt) Psca: antigénio de células estaminais da próstata e suas utilizações
IL142824A0 (en) Lipoic acid derivatives and their use in treatment of disease
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
DE69906992D1 (de) Zweite medizinische indikation einer partikelverabreichungsmethode
EA200000109A1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
AU7100898A (en) Means of ascertaining an individual's risk profile for atherosclerotic disease
DE602004019812D1 (de) Marker für neuromyelitis optica
Saini et al. Development of a simple enzyme immunoassay for blood haptoglobin concentration in cattle and its application in improving food safety
CY1105322T1 (el) Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων
BRPI0513896A (pt) método para a discriminação entre tecido saudável e de tumor
ATE356357T1 (de) Prostatakrebs-marker
FI941832A0 (fi) Menetelmiä NMR:llä havaittavien ksenobioottisten yhdisteiden in vivo määrittämiseksi
DE60207733D1 (de) Abbildung von transgenen markern
de Groene et al. Pigs in the Neolithic of the eastern Fertile Crescent: New evidence from Pre‐Pottery Neolithic Bestansur and Shimshara, Iraqi Kurdistan (7800–7100 BC)
DE60032784D1 (de) Markerproteine für prostatakrebs
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
NO20011394D0 (no) Mammoglobin, et sekrert brystspesifikt brystkreftprotein
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
EP1621616A4 (de) Menschlicher anti-mensch-interleukin-18-antikörper, fragment davon und verfahren zu deren verwendung
RU2008111144A (ru) Способы моделирования и ингибирования миграции раковых клеток
WO2003063059A3 (en) Method for positively identifying livestock and use thereof in legal instruments relating thereto
Neveu Collado et al. Human and camelid paleodiets in El Bolson valley (NW Argentina): A stable isotope approach
WO2003008973A3 (en) Diagnostic markers for determination of the life stage of a non-human animal and classification system based thereon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties